2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Breast Neoplasms
6
Colorectal Neoplasms
5
Neoplasms
4
Stomach Neoplasms
3
Malnutrition
3
Lung Neoplasms
3
Diarrhea
3
Uterine Cervical Neoplasms
2
Mucositis
2
Inflammation
2
Enteritis
2
Chalazion
2
Carcinoma, Hepatocellular
2
Thyroid Neoplasms
1
Squamous Intraepithelial Lesions
1
Smoldering Multiple Myeloma
1
Radiation Injuries
1
Psychological Well-Being
1
Psoriasis Vulgaris
1
Polycystic Ovary Syndrome
1
Periampullary Carcinoma Nos
1
Pelvic Neoplasms
1
Pelvic Inflammatory Disease
1
Papillomavirus Infections
1
Ovarian Neoplasms
1
Neoplasms, Second Primary
1
Muscle Invasive Bladder Cancer (MIBC)
1
Multiple Myeloma
1
Motor Activity
1
Monoclonal Gammopathy of Undetermined Significance
1
Interventions
Trimethoprim, Sulfamethoxazole Drug Combination
9
Ciprofloxacin
8
Voriconazole
5
Vancomycin
4
Caspofungin
4
Amoxicillin-Potassium Clavulanate Combination
4
gamma-Globulins
3
Fluconazole
3
Filgrastim
3
Daptomycin
3
Antibiotic Prophylaxis
3
plerixafor
2
liposomal amphotericin B
2
Whole-Body Irradiation
2
Trimethoprim
2
Therapeutics
2
Sulfamethoxazole
2
Saline Solution
2
Ribavirin
2
Polymerase Chain Reaction
2
Piperacillin, Tazobactam Drug Combination
2
Peripheral Blood Stem Cell Transplantation
2
Pentetic Acid
2
Moxifloxacin
2
Melphalan
2
Levofloxacin
2
Lenalidomide
2
Itraconazole
2
Immunoglobulins, Intravenous
2
Granulocyte Colony-Stimulating Factor
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Infections
×
Probiotics
×
Clear all
NCT03785938
2018-12-24
MaCROS
University of Leeds
Phase NA
Unknown
40 enrolled